Coronavirus (COVID 19) Infection in Pregnancy
Abstract
Coronavirus illness 2019 (COVID-19) is an airways infection caused by the new coronavirus (SARS-CoV-2) which has been quickly disseminated all over the world, affecting to the general population including women in pregnancy time. As being a recent infection, the evidence that supports the best practices for the management of the infection during pregnancy is limited, and most of the questions have not been completely solved yet.
This publication offers general guidelines focused on decision-making people, managers, and health’s teams related to pregnant women attention and newborn babies during COVID-19 pandemic. Its purpose is to promote useful interventions to prevent new infections as well as prompt and adequate attention to avoid serious complications or deaths, trying to be adapted to the different contexts in which attention to expectant mothers is provided. Guidelines are set within a well-scientific evidence and available recommendations up to date.
Authors
Downloads
Keywords
- COVID-19
- pregnancy
- Newborn
- Hand Disinfection
- Amniotic Fluid
- SARS COV-2 virus
Author Biographies
, Professor of the Department of Obstetrics and Gynecology of the Universidad del Valle
Surgeon, Specialist in Obstetrics and Gynecology and Master in Public Health at Universidad del Valle.
Professor of the Department of Obstetrics and Gynecology of the Universidad del Valle since 1984.
Former President Colombian Federation of Obstetrics and Gynecology - FECOLSOG
Former President of the Latin American Federation of Obstetrics and Gynecology - FLASOG.
Member of the Executive Board and the Scientific Committee of the International Federation of Gynecology and Obstetrics-FIGO
Distinguished as Master of Gynecology and Obstetrics of Colombia in 2016.
Fellow of the American College of Obstetrics and Gynecology.
https://orcid.org/0000-0001-8625-659X, Universidad del Valle
Full professor Universidad del Valle, Hospital Universitario del Valle
Department of gynecology and Obstetrics.
Education: Gynecologist, Human reproduction and gynecological.
endocrinology, MSc .universidad del valle.
Postdoctorate in Human Reproduction, Monash University.
https://orcid.org/0000-0003-2969-8767
Clinical experience.
Infertility treatments and gynecological endocrinology, microsurgery and endoscopic surgery in reproduction. Assisted Reproduction Techniques.
Investigation area
Endocrinology, reproductive problems in the male factor and reproductive surgery.
Selected Items.
Herrera M., J.A., Herrera, M.R., Herrera, E.J.P., Nieto, D.A. Reduction of maternal mortality due to preeclampsia in Colombia-an interrupted time-series analysis 2014 Colombia Medica. https://doi.org/10.25100/cm.v45i1.1466
Herrera, E., Otero, E., Hincapié, L.C., (...), Paz, L.F., Otero, P. Heterotopic pregnancy. Presentation of four cases | [Embarazo heterotópico. Presentación de cuatro casos] 2011 Colombia Medica. https://doi.org/10.25100/cm.v42i4.953
Saldarriaga, W., Herrera, E., Castro, D. Myasis in uterine prolapse, successful treatment .2011. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2011.03.019
Herrera, J.A., Parra, B.,Herrera, E., (...), Contreras, A., López-Jaramillo, P.Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. 2007 Journal of Hypertension. https://doi.org/10.1097/HJH.0b013e3281139ea9
, Centro Médico Imbanaco
Physician and surgeon graduated from Universidad del Valle in Cali-Colombia, with postgraduate studies in Epidemiology and Public Health from Michigan State University and Johns Hopkins University
He has worked at the Pan American Health Organization / World Health Organization (PAHO / WHO) and the Inter-American Development Bank (IDB) in Washington, D.C. and Panama.
He is currently the Scientific Director of the Imbanaco Medical Center and a volunteer professor in the Department of Public Health Sciences, School of Medicine, University of Miami
https://orcid.org/0000-0002-3902-5294References
WHO. Household transmission investigation protocol for coronavirus disease 2019 (COVID-19): 2020
AL Phelan, R Katz, LO Gostin. The Novel Coronavirus Originating in Wuhan, China Challenges for Global Health Governance. JAMA, 323: 709-710, 2020. DOI: http://dx.doi.org/10.1001/jama.2020.1097
T Liang, H Cai, Y Chen, Z Chen, Q Fang, W Han. Handbook of COVID-19 Prevention and treatment: 2020
Organización Panamericana de la Salud. Enfermedad por el Coronavirus (COVID-19): OPS, Washington, D.C., 2020
J Qiao. What are the risks of COVID-19 infection in pregnant women. Lancet, 395: P760-P762, 2020. DOI: http://dx.doi.org/10.1016/S0140-6736(20)30365-2
H Chen, J Guo, C Wang, F Luo, X Yu. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women a retrospective review of medical records.Lancet, 395: P809-P815, 2020 DOI: http://dx.doi.org/10.1016/S0140-6736(20)30360-3
DA Schwartz, AL Graham. Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019-nCoV infecting pregnant women Lessons from SARS, MERS, and other human Coronavirus infections.Viruses, 12: 2020 DOI: http://dx.doi.org/10.3390/v12020194
L Dong, J Tian, S He, C Zhu, J Wang, C Liu. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA: 2020 DOI: http://dx.doi.org/10.1001/jama.2020.4621
H Zeng, C Xu, J Fan, Y Tang, Q Deng, W Zhang. Antibodies in infants born to mothers with COVID-19 pneumonia.JAMA: 2020. DOI: http://dx.doi.org/10.1001/jama.2020.4861
H Chen, J Guo, C Wang, F Luo, X Yu, W Zhang. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women a retrospective review of medical records. Lancet, 395: 809-815, 2020. DOI: http://dx.doi.org/10.1016/S0140-6736(20)30360-3
Centers for Disease Control and Prevention (CDC).Interim infection prevention and control recommendations for patients with suspected or confirmed Coronavirus disease 2019 (COVID-19) in healthcare settings: 2020
SWX Ong, YK Tan, PY Chia, TH Lee, OT Ng, MSY Wong. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA: 2020. DOI: http://dx.doi.org/10.1001/jama.2020.3227
JA Benavides, M Parra-Saavedra, J Miranda, C Ramírez, JL Silva, JE Sanin-Blair
Comunicado enfermedad por coronavirus SARS-CoV-2 (COVID-19) en embarazo: 2020
Thomas Jefferson University Department of Obstetrics and Gynecology. Jefferson Labor & Delivery COVID19 PREPAREDNESS, Philadelphia, 2020
Fetal Medicina. Protocolo: coronavirus (covid-19) y embarazo: 2020
Comité de Anestesia Obstétrica, Sociedad Colombiana de Anestesia y Reanimación. Analgesia y anestesia en la gestante con sospecha o diagnóstico de COVID 19: 2020
EI Ortiz, D Gallo. Protocolo de atención SARS-CoV-2 y embarazo: 2020
Grupo ACIN- IETS de Consenso Colombiano para recomendaciones de atención COVID19.Infectio, 24: 2020. DOI: http://dx.doi.org/10.22354/in.v24i3.851
Ministerio de Salud y Protección Social. Lineamientos provisionales para la atención en salud de las gestantes, recién nacidos y para la lactancia materna, en el contexto de la pandemia de COVID-19 en Colombia: 2020
Copyright (c) 2020 Universidad del Valle
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
